Ticker Launch
Sign inTry it free

SPAC · Merger completed

Oaktree Acquisition Corp. II

Business combination with Alvotech

Oaktree Acquisition Corp. II is a blank-check company (SPAC) that raised $225M in its initial public offering on Sep 18, 2020, listing on New York Stock Exchange. It completed its business combination with Alvotech on Jun 15, 2022; the combined company is Alvotech (TopCo) (ALVO). Evercore ISI led the IPO, with Blackstone and Lumeta. Kirkland & Ellis advised the SPAC and Ropes & Gray advised the underwriters on the IPO.

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. It is the target of a proposed business combination with a special purpose acquisition company.

Status
Merger completed
IPO date
Sep 18, 2020
IPO size
$225M
IPO exchange
New York Stock Exchange
Target
Alvotech
Announced
Dec 7, 2021
Closed
Jun 15, 2022
Combined company
Alvotech (TopCo) (ALVO)
IPO underwriters
Evercore ISI, Blackstone and Lumeta
SPAC counsel (IPO)
Kirkland & Ellis and Walkers
Underwriters' counsel (IPO)
Ropes & Gray

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022